Detalhe da pesquisa
1.
Experimental laboratory biomarkers in multiple sclerosis.
Wien Med Wochenschr
; 172(15-16): 346-358, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254566
2.
The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis.
Medicina (Kaunas)
; 58(11)2022 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36363469
3.
Month-of-birth-effect in multiple sclerosis in Austria.
Mult Scler
; 25(14): 1870-1877, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30463473
4.
Real-life use of oral disease-modifying treatments in Austria.
Acta Neurol Scand
; 140(1): 32-39, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30958901
5.
Do elevated autoantibodies in patients with multiple sclerosis matter?
Acta Neurol Scand
; 139(3): 238-246, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447159
6.
From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.
Clin Immunol
; 176: 87-93, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28108364
7.
Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Int J Mol Sci
; 16(9): 21832-45, 2015 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26378517
8.
FADD is upregulated in relapsing remitting multiple sclerosis.
Neuroimmunomodulation
; 21(5): 221-5, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24603611
9.
Early intensive versus escalation treatment in patients with relapsing-remitting multiple sclerosis in Austria.
J Neurol
; 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430270
10.
Sex impacts treatment decisions in multiple sclerosis.
J Neurol
; 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441611
11.
Multiple sclerosis in the elderly: a retrospective cohort study.
J Neurol
; 271(2): 674-687, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855871
12.
TRAF2 is upregulated in relapsing-remitting multiple sclerosis.
Neuroimmunomodulation
; 20(3): 177-83, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23595117
13.
Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?
Clin Chem Lab Med
; 51(11): 2073-86, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23729569
14.
Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing-remitting multiple sclerosis in Austria.
J Neurol
; 270(6): 3103-3111, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862148
15.
Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).
J Neurol
; 270(8): 3779-3786, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074388
16.
Serum from interferon-ß-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.
Mult Scler
; 18(2): 236-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21844066
17.
Biomarkers of inflammation and endothelial dysfunction in stroke with and without sleep apnea.
Cerebrovasc Dis
; 33(5): 453-60, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22488018
18.
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Wien Med Wochenschr
; 162(15-16): 354-66, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895849
19.
Laboratory biomarkers of Multiple Sclerosis (MS).
Clin Biochem
; 99: 1-8, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673037
20.
Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry.
J Neurol
; 268(11): 4303-4310, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33890167